NAD+ 1G & RETATRUTIDE - A UK UPDATE

NAD+ 1g & Retatrutide - A UK Update

The growing landscape of metabolic health in the UK is seeing increasing interest in the synergy of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or its similar Tirzepatide). Clinicians are observing potential

read more